psicose, (d)-isomer has been researched along with Obesity in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 10 (47.62) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; Kaneko, K; Seino, Y; Wang, L; Yabe, D; Yada, T; Yermek, R | 1 |
| Han, W; Kaneko, K; Rakhat, Y; Seino, Y; Wang, L; Yabe, D; Yada, T | 1 |
| Akimitsu, K; Iida, T; Matsuo, T; Mochizuki, S; Yamada, T; Yoshihara, A | 1 |
| Harada, A; Miyake, K; Nakamura, T; Okito, M; Tamiya, T; Yamazaki, M | 1 |
| Bae, HR; Han, Y; Kim, S; Kwon, EY; Shin, SK; Yoo, JH; Young, HA | 1 |
| Choi, MS; Han, Y; Yoon, J | 1 |
| Choi, BR; Choi, MS; Han, Y; Ji, Y; Kwon, EY; Park, H | 1 |
| Choi, MS; Han, Y; Kwon, EY | 1 |
| Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Jinawong, K; Kerdphoo, S; Pongkan, W; Pratchayasakul, W; Tokuda, M | 1 |
| Arunsak, B; Chattipakorn, N; Chattipakorn, SC; Chunchai, T; Jaiwongkam, T; Jinawong, K; Pongkan, W; Pratchayasakul, W; Tokuda, M | 1 |
| Aoki, R; Arai, T; Dezaki, K; Drucker, DJ; Goswami, C; Hara, H; Hayakawa, M; Hira, T; Iwasaki, Y; Kumari, P; Masuda, C; Nakata, M; Okada, T; Sato, T; Sendo, M; Tokuda, M; Yada, T; Yamada, Y | 1 |
| Choi, MS; Han, Y; Kim, HJ; Kim, SB; Kim, YH; Kwon, EY; Lee, SJ; Yu, MK | 1 |
| Chen, J; Huang, W; Jiang, B; Lu, M; Zhang, T | 1 |
| Iida, T; Matsuo, T; Ochiai, M; Onishi, K; Yamada, T | 1 |
| Dong, Y; Hirata, Y; Hirose, K; Hossain, A; Kamitori, K; Katagi, A; Matsunaga, T; Noguchi, C; Sui, L; Tokuda, M; Tsukamoto, I; Yamaguchi, F | 1 |
| Hama, S; Hossain, A; Ishihara, Y; Itoh, K; Kawamata, M; Mizuno, S; Oshima, W; Tokuda, M | 1 |
| Hossain, A; Matsuo, T; Nagata, Y; Ogawa, M; Tokuda, M; Toyoda, Y; Tsukamoto, I; Yamaguchi, F | 1 |
| Cho, SJ; Choi, JY; Choi, MS; Han, HJ; Han, Y; Jung, UJ; Kim, AH; Park, YB | 1 |
| Chung, MY; Lee, KW; Oh, DK | 1 |
| Chung, YM; Hong, YH; Hwang, SH; Hye Park, C; Hyun Lee, J; Jin Lee, S; Kim, SB; Youl Kim, D | 1 |
| Dong, Y; Hirata, Y; Hossain, A; Kamitori, K; Matsunaga, T; Sui, L; Tokuda, M; Tsukamoto, I; Ueno, M; Yamaguchi, F | 1 |
2 review(s) available for psicose, (d)-isomer and Obesity
| Article | Year |
|---|---|
Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Drug Monitoring; Fructose; Glucose; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Liver; Obesity | 2015 |
Hypoglycemic health benefits of D-psicose.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Fructose; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Obesity; Sweetening Agents | 2012 |
1 trial(s) available for psicose, (d)-isomer and Obesity
| Article | Year |
|---|---|
A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Abdominal Fat; Adiposity; Adult; Anti-Obesity Agents; Biomarkers; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fructose; Humans; Inflammation Mediators; Lipids; Male; Obesity; Preliminary Data; Republic of Korea; Subcutaneous Fat; Sweetening Agents; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss; Young Adult | 2018 |
18 other study(ies) available for psicose, (d)-isomer and Obesity
| Article | Year |
|---|---|
D-Allulose cooperates with glucagon-like peptide-1 and activates proopiomelanocortin neurons in the arcuate nucleus and central injection inhibits feeding in mice.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Fructose; Glucagon-Like Peptide 1; Mice; Neurons; Obesity; Pro-Opiomelanocortin | 2022 |
d-Allulose Inhibits Ghrelin-Responsive, Glucose-Sensitive and Neuropeptide Y Neurons in the Arcuate Nucleus and Central Injection Suppresses Appetite-Associated Food Intake in Mice.
Topics: Animals; Appetite; Arcuate Nucleus of Hypothalamus; Eating; Fructose; Ghrelin; Glucose; Hyperphagia; Mice; Neurons; Neuropeptide Y; Obesity; Rats; Rats, Sprague-Dawley | 2022 |
Dietary D-Allulose Reduces Body Fat Accumulation in Rats with and without Medium-Chain Triacylglycerol Supplementation.
Topics: Adipose Tissue; Animals; Diet; Dietary Fats; Dietary Supplements; Fructose; Humans; Obesity; Rats; Triglycerides | 2022 |
d-Allulose Supplementation Prevents Diet-Induced Hepatic Lipid Accumulation via miR-130-Mediated Regulation in C57BL/6 Mice.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Water | 2023 |
D-Allulose Ameliorates Dysregulated Macrophage Function and Mitochondrial NADH Homeostasis, Mitigating Obesity-Induced Insulin Resistance.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Homeostasis; Humans; Inflammation; Insulin Resistance; Insulins; Macrophages; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Obesity | 2023 |
Tracing the Anti-Inflammatory Mechanism/Triggers of d-Allulose: A Profile Study of Microbiome Composition and mRNA Expression in Diet-Induced Obese Mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Diet, High-Fat; Dietary Supplements; Fructose; Gastrointestinal Microbiome; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mice, Obese; Obesity | 2020 |
Alteration of Microbiome Profile by D-Allulose in Amelioration of High-Fat-Diet-Induced Obesity in Mice.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Fructose; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Obesity | 2020 |
Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of mRNA Expression and Alteration of the Microbiome Composition.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Supplements; Fructose; Gastrointestinal Microbiome; Glucose; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Obesity; Phytotherapy; RNA, Messenger | 2020 |
D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats.
Topics: Animals; Diet, High-Fat; Fructose; Insulin; Insulin Resistance; Male; Mitochondria, Heart; Obesity; Rats; Rats, Wistar | 2021 |
Not only metformin, but also D-allulose, alleviates metabolic disturbance and cognitive decline in prediabetic rats.
Topics: Animals; Cognitive Dysfunction; Diet, High-Fat; Drinking Water; Fructose; Insulin Resistance; Insulins; Metformin; Obesity; Prediabetic State; Rats; Rats, Wistar | 2022 |
GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Eating; Fructose; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Hyperphagia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Rats; Rats, Wistar; Vagus Nerve | 2018 |
Anti-obesity potential of rare sugar d-psicose by regulating lipid metabolism in rats.
Topics: Animals; Anti-Obesity Agents; fas Receptor; Fructose; Glucose; Humans; Insulin; Lipid Metabolism; Lipids; Male; Obesity; PPAR alpha; Rats; Rats, Wistar; Sterol Regulatory Element Binding Protein 1 | 2019 |
D-psicose increases energy expenditure and decreases body fat accumulation in rats fed a high-sucrose diet.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Diet; Dietary Sucrose; Energy Metabolism; Fructose; Male; Obesity; Rats; Rats, Wistar | 2014 |
Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.
Topics: Abdominal Fat; Adiposity; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Fructose; Glycated Hemoglobin; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Insulin-Secreting Cells; Obesity; Rats, Inbred OLETF; Time Factors; Weight Gain | 2015 |
Beneficial Effects of Supplementation of the Rare Sugar "D-allulose" Against Hepatic Steatosis and Severe Obesity in Lep(ob)/Lep(ob) Mice.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Body Composition; Body Weight; Cell Differentiation; Dietary Supplements; Fatty Liver; Fructose; Leptin; Liver; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Organ Size | 2015 |
d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition.
Topics: Adiposity; Animals; Apolipoprotein B-48; Blood Glucose; Body Weight; CD36 Antigens; Diet, High-Fat; Dietary Supplements; Fatty Acid Transport Proteins; Fructose; Gene Expression Regulation; Glucose; Leptin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Resistin; Sweetening Agents | 2016 |
Dietary D-psicose reduced visceral fat mass in high-fat diet-induced obese rats.
Topics: Adipocytes; Animals; Body Composition; Body Weight; Diet, High-Fat; Dietary Supplements; Energy Intake; Fructose; Intra-Abdominal Fat; Lipoproteins, HDL; Lipoproteins, LDL; Male; Obesity; Rats; Rats, Sprague-Dawley | 2012 |
Rare sugar D-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats.
Topics: Abdominal Fat; Actins; Adipokines; Animals; Body Mass Index; Body Weight; Cytoprotection; Diabetes Mellitus, Type 2; Eating; Fibrosis; Fructose; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Obesity; Rats; Rats, Inbred OLETF | 2012 |